Article
MGMT promoter methylation prediction based on multiparametric MRI via vision graph neural network
16 Feb 2024
Abstract excerpt
PurposeGlioblastoma (GBM) is aggressive and malignant. The methylation status of the O6‐methylguanine‐DNA methyltransferase (MGMT) promoter in GBM tissue is considered an important biomarker for developing the most effective treatment plan. Although the standard method for assessing the MGMT promoter methylation status is via bisulfite modification and deoxyribonucleic acid (DNA) sequencing of biopsy or surgical...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
